𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PND9 COST UTILITY ANALYSIS OF LEVODOPA-CARBIDOPA VS LEVODOPA-CARBIDOPA-ENTACAPONE IN PARKINSON DISEASE IN MEXICO

✍ Scribed by F Garcia-Contreras; A Nevarez-Sida; P Constantino-Casas; E Rojas-Martínez; M García-Constantino; G Del Angel-García


Book ID
119594638
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
72 KB
Volume
9
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Double-blind trial of levodopa/carbidopa
✍ Robert A. Hauser; Michel Panisset; Giovanni Abbruzzese; Linda Mancione; Nalina D 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

## Abstract We performed a 39‐week, randomized, double‐blind, multicenter study to compare the efficacy, safety, and tolerability of levodopa/carbidopa/entacapone (LCE, Stalevo) with levodopa/carbidopa (LC, Sinemet IR) in patients with early Parkinson's disease (PD). Four hundred twenty‐three patie

Quality of life in early Parkinson's dis
✍ Victor S.C. Fung; Lilie Herawati; Ying Wan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract We aimed to investigate whether treatment with levodopa/carbidopa/entacapone when compared with levodopa/carbidopa improves quality of life in Parkinson's disease (PD) patients with no or minimal, nondisabling motor fluctuations. This is a multicenter, randomized, double‐blind study. On